[email protected] +1 (304) 306-0723

Home
About Us
Services
Case Studies
Blog
Report Store
Contact Us
- My account
Products search

Cart

No products in the cart.

View Cart Checkout

High grade intraepithelial lesion

Showing the single result

High grade intraepithelial lesion (HSIL) | Primary Research (KOL’s Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
$6,500.00 – $19,500.00 Select options

Search for:

Filter by price

Price: —

Product categories

Market Forecast 24
Therapeutic Area 17
- Central Nervous System 4
- Endocrinology 2
- Genetic Disorders 1
- Oncology 6
- Ophthalmology 2
- Pre-cancerous (Infections) 1
- Renal Diseases / Nephrology 2
- Sleep Disorders 1
Therapy Reports 18

Latest Products

Adult Acute Lymphoblastic Leukemia (aALL) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030 $6,500.00 – $19,500.00
Chimeric Antigen Receptor (CAR-T) Cell Therapy – Market Opportunity, Pipeline & Competitive Intelligence 2020 $2,400.00 – $7,200.00
Peripheral T-cell lymphoma (PTCL)| Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2030 $6,500.00 – $19,500.00

Customised Report

Looking for a customised Report. Send the details to us.

Request for Customised Report

Get In Touch

Let's keep the conversation going

DELIVERING STRATEGIES THAT MAKES THE DIFFERENCE

Mellalta Meets is where imagination meets excellence, we champion the bold and help in achieving companies the extraordinary.

Documents

Fast Facts PDF Document

Financial Information PDF Document

Recent Posts

Y-mabs’ Danyelza for R/R High-Risk Neuroblastoma: Business & Launch Strategies December 3, 2020
Eleven Global Partners one Technology: Halozyme ENHANZE technology October 15, 2020

Contact Us

+1 (304) 306-0723
[email protected]

Mellalta Meets - Excellence Reimagined

Copyright 2020